Impact of novel hemophilia therapies around the world
Abstract Hemophilia A and B are hereditary bleeding disorders, characterized by factor VIII or IX deficiencies, respectively. For many decades, prophylaxis with coagulation factor concentrates (replacement therapy) was the standard‐of‐care approach in hemophilia. Since the 1950s, when prophylaxis st...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2022-03-01
|
| coleção: | Research and Practice in Thrombosis and Haemostasis |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/rth2.12695 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|